GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (MEX:TAK N) » Definitions » Moat Score

Takeda Pharmaceutical Co (MEX:TAK N) Moat Score : 6/10 (As of Jul. 13, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Takeda Pharmaceutical Co Moat Score?

Takeda Pharmaceutical Co has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Takeda Pharmaceutical Co has Narrow Moat: Takeda has a strong narrow moat due to its valuable patents, significant R&D capabilities, and strong brand in the pharmaceutical industry. However, it faces competition from other large pharmaceutical companies, limiting its pricing power and market share.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Takeda Pharmaceutical Co might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Competitive Comparison of Takeda Pharmaceutical Co's Moat Score

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Takeda Pharmaceutical Co's Moat Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Moat Score distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Moat Score falls into.


;
;

Takeda Pharmaceutical Co  (MEX:TAK N) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Takeda Pharmaceutical Co Moat Score Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Moat Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (MEX:TAK N) » Definitions » Moat Score
Comparable Companies
TSE:4507 TSE:4523 TSE:4506 TSE:4530 TSE:4540 TSE:4887 TSE:4516 TSE:4551 TSE:4547 TSE:4521 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA SHSE:688506
Traded in Other Exchanges
TAK:USA TKPHF:USA 4502:Japan 4502:Japan 4502:Japan 0A87:UK TKDA:Germany TKD:Germany TKD:Germany TKD:Germany TAKP34:Brazil TKD:Austria
Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Website
https://www.takeda.com
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co Headlines

No Headlines